Near-infrared light-activated cancer cell targeting and drug delivery with aptamer-modified nanostructures

被引:0
作者
Yu Yang
Jingjing Liu
Xiaoqi Sun
Liangzhu Feng
Wenwen Zhu
Zhuang Liu
Meiwan Chen
机构
[1] University of Macau,State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences
[2] Soochow University,Institute of Functional Nano & Soft Materials Laboratory (FUNSOM)
来源
Nano Research | 2016年 / 9卷
关键词
near-infrared (NIR)-activable; drug delivery; aptamer; gold nanorods; single-walled carbon nanotubes;
D O I
暂无
中图分类号
学科分类号
摘要
Stimuli-activated targeted delivery systems for highly accurate treatment of tumors have received considerable attention in recent years. Herein, we reveal a light-activable cancer-targeting strategy that uses a complementary DNA sequence to hybridize and mask sgc8 aptamers conjugated onto photothermal agents such as gold nanorods or single-walled carbon nanotubes (SWNTs). Upon exposure to near-infrared (NIR) laser, localized photothermal heating of the surface of those nano-agents results in dehybridization of the double-stranded DNA and uncaging of the aptamer sequence to allow specific cancer-cell targeting. Utilizing doxorubicin-loaded SWNTs as a model system, targeted drug delivery to cancer cells activated by NIR light was achieved. This work demonstrates the concept of NIR-activable tumor-targeting delivery systems with controllable cancer-cell binding to potentially enable highly specific and efficient cancer therapy.
引用
收藏
页码:139 / 148
页数:9
相关论文
共 255 条
  • [1] Allen T. M.(2004)Drug delivery systems: Entering the mainstream Science 303 1818-1822
  • [2] Cullis P. R.(2011)Facile preparation of multifunctional upconversion nanoprobes for multimodal imaging and dual-targeted photothermal therapy Angew. Chem. 123 7523-7528
  • [3] Cheng L.(2015)Remotely controlled red blood cell carriers for cancer targeting and near-infrared light-triggered drug release in combined photothermal–chemotherapy Adv. Funct. Mater. 25 2386-2394
  • [4] Yang K.(1981)IgG antibodies to phosphorylcholine exhibit more diversity than their IgM counterparts Nature 291 29-34
  • [5] Li Y. G.(2006)Aptamer: Toxin conjugates that specifically target prostate tumor cells Cancer Res. 66 5989-5992
  • [6] Chen J. H.(2004)Nanoparticle-aptamer bioconjugates: A new approach for targeting prostate cancer cells Cancer Res. 64 7668-7672
  • [7] Wang C.(2010)A drug-loaded aptamer–gold nanoparticle bioconjugate for combined CTimaging and therapy of prostate cancer ACS Nano 4 3689-3696
  • [8] Shao M. W.(2013)Magnetic field triggered drug release from polymersomes for cancer therapeutics J. Control. Release 169 165-170
  • [9] Lee S.-T.(2008)Microbubbles in ultrasoundtriggered drug and gene delivery Adv.Drug Deliv. Rev. 60 1153-1166
  • [10] Liu Z.(2011)Self-assembled liposome-loaded microbubbles: The missing link for safe and efficient ultrasound triggered drug-delivery J. Control. Release 152 249-256